YieldMax Universe Fund of Option Income ETFs (YMAX) Stock Price Today
Aura AI Summary
Key Stats
- -Market Cap
- -Volume
- Income / Options OverlaySector
- $13.1452W High
- $7.2752W Low
- -Typical Hold Time
- -Enterprise Value
- -Div Yield
- -Trading Activity
Track YieldMax Universe Fund of Option Income ETFs (YMAX) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, YieldMax Universe Fund of Option Income ETFs has traded between a low of $7.27 and a high of $13.14, highlighting its annual price range. Buy and sell YieldMax Universe Fund of Option Income ETFs shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About YieldMax Universe Fund of Option Income ETFs
YMAX is an actively managed 'fund of funds' that provides equal-weighted exposure to the full suite of YieldMax option income ETFs. It is designed to generate high current income by aggregating the premiums from various single-stock and thematic covered call strategies, offering a diversified approach to high-yield option investing.
Most Recent News
Ethereum ETFs see $24M outflow after $824M inflow week, signaling a possible pause, not a trend shift.
Ethereum ETFs experienced a $24.29 million outflow on September 8, 2026, following two weeks of record inflows totaling over $1 billion. Most of the outflow came from Grayscale's funds, which have a history of outflows, while BlackRock's and Fidelity...

Class action lawsuit filed against TruGolf for alleged securities violations and share dilution.
A class action lawsuit has been filed against TruGolf Holdings, Inc. and certain officers for alleged violations of federal securities laws during September 2025 to May 2026. The lawsuit claims TruGolf failed to disclose significant dilution caused b...

Class action lawsuit filed against Replimune for alleged securities law violations over misleading FDA data disclosures.
A class action lawsuit has been filed against Replimune Group, Inc. and some of its officers for allegedly making false statements and failing to disclose critical information about FDA study design concerns and incomplete data submissions during Oct...

People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.